Sowjanya T, Dhanasri K, Kedhareswari D, Vani C, Keerthi B, VaniHepsiba B. Heterocyclic Tyrosine Kinase Inhibitors: Structural Insights and Medicinal Chemistry Strategies in Cancer, Immune-Mediated Disorders and Myeloproliferative Neoplasms. Adolescência e Saúde [Internet]. 2026 Oct. 4 [cited 2026 Oct. 20];:2011-20. Available from: https://adolescenciaesaude.com/index.php/aes/article/view/2733